This trial is evaluating whether Questionnaire Administration will improve 1 primary outcome, 2 secondary outcomes, and 4 other outcomes in patients with Atypical Ductal Hyperplasia. Measurement will happen over the course of Baseline to 12 weeks.
This trial requires 40 total participants across 2 different treatment groups
This trial involves 2 different treatments. Questionnaire Administration is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"At present, the mainstay of treatment is based on behavioural therapy with calorie restriction combined with physical activities such as aerobic exercises and resistance training. Although the effectiveness of these interventions has been established, the maintenance of long-term changes remains elusive. Besides, lifestyle modification programs are typically targeted towards improving patients' overall health rather than weight loss. More research is needed to explore whether the newer pharmacological therapies could be effective in achieving weight loss." - Anonymous Online Contributor
"Clinical trial participation was strongly associated with several demographic characteristics. More than half of participants who reported being willing to participate in a clinical trial were not enrolled." - Anonymous Online Contributor
"The number of people who get weight loss in the U.S. is relatively small. This may be due to the fact that obesity prevalence is rising as a result of an increase in sedentary lifestyles. While there are numerous health benefits associated with losing weight, the cost of achieving this goal needs to be taken into consideration." - Anonymous Online Contributor
"The reasonably high level of missing data suggests that the inventory may have been poorly received by study participants. However, the findings of moderate correlations among the items and their subscales suggest that this type of instrument could serve as an appropriate proxy measure of post-intervention change. This might be helpful in assessing the impact of multi-component weight management programs such as the DASH diet." - Anonymous Online Contributor
"Aside from being a useful tool to identify patients who are likely to benefit from treatment, the questionnaire was easily administered and might be useful in detecting patients who are at risk for underreporting their actual weight loss. In addition, the patient's knowledge of his/her progress might influence his/her motivation level to lose weight." - Anonymous Online Contributor
"The current study showed that the use of pen and ink and computerized formats resulted in higher data quality than paper and pencil. However, there were no differences between the two formats with respect to patient satisfaction. In future studies, paper and pencil would probably be preferable given the limited time resources faced by clinicians and researchers." - Anonymous Online Contributor
"The questionnaire was well accepted by patients and physicians. Furthermore, it had acceptable psychometric properties. Questionnaire administration may be a useful tool for screening for depression among patients undergoing weight loss surgery." - Anonymous Online Contributor
"There is no single reason why people lose weight; rather, many factors contribute to weight loss. Body fat distribution and nutritional habits play a major role in determining how much weight a person will lose. More research needs to be conducted to better understand weight loss." - Anonymous Online Contributor
"This pilot study showed that patients' changes were rapid. The greatest changes occurred at 1 year postoperatively. However, the results also show that there may be continuing change even at 3 years. The findings support the need for further research into the long-term effects of bariatric surgery." - Anonymous Online Contributor
"Although this study has several limitations, we suggest that further research into familial effects of weight loss may help clarify the genetic basis of obesity." - Anonymous Online Contributor
"The current data suggest that substantial weight loss is achievable after a short period of time and that there is a high probability of sustained weight regain following cessation of the treatment. Thus it appears that although weight loss is not cure, it does appear to be possible to achieve significant weight loss in a relatively short time frame and then manage successfully to prevent weight regain." - Anonymous Online Contributor